Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparable Efficacy of Transcranial Direct Current Stimulation and Pharmacological Treatments in Children With Autism Spectrum Disorder

NCT05491720 is registered in ClinicalTrials.gov with The National Brain Mapping Laboratory (NBML) as lead sponsor.

NCT NCT05491720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05491720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparable Efficacy of Transcranial Direct Current Stimulation and Pharmacological Treatments in Children With Autism Spectrum Disorder
Lead sponsor
The National Brain Mapping Laboratory (NBML)
Phase
Phase 1
Overall status
Completed
Start date
August 15, 2020
Completion date
August 3, 2022
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder